The global parenteral nutrition market size expected to reach at USD 8.36 billion by 2026. The global parenteral nutrition market is expected to expand at a CAGR of more than 5.9% from 2018 to 2026. The developing predominance of malnutrition and perpetual conditions along with rising geriatric populace is projected to drive the global parental nutrition market growth over the forecast period.
The global parental nutrition market is segmented into nutrient type and region. On the basis of nutrient type, the global market is segmented into carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins & minerals. On the basis of geography, the global market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
Market Segmentation by Nutrient Type:
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Trace Elements
- Vitamins & Minerals
Market Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
The U.S. market is assessed to develop at a CAGR of 3.3 percent over the gauge time frame. The U.S. speaks to a noteworthy provincial market share pursued by Canada. The parenteral nourishment market in the Asia Pacific is anticipated to grow at an outstanding CAGR of 7.9% amid the figure time frame. The high pervasiveness of unending kidney issue in exceptionally populated nations, for example, China and India, quick improvement in social insurance framework, increment in access to medicinal services offices and ascend in per capita human services use in the area are probably going to fuel the market in the Asia Pacific amid the figure time frame.
Major companies contributing the global parenteral nutrition market are Actavis, Inc., Aculife (Nirlife), B. Braun Melsungen AG, Baxter International, Inc., Fresenius Kabi AG, Grifols International S.A., Hospira, Inc., Otsuka Pharmaceutical Factory, Inc., Sichuan Kelun Pharmaceutical Co. Ltd., and Vifor Pharma.